Jasinski: Pharmacy Benefit Manager reforms will lead to cheaper prescription drugs

The Minnesota Senate today unanimously passed a bill to improve oversight of Pharmacy Benefit Managers (PBMs), the middlemen in the supply chain of getting medicines to patients. This bill requires transparency and accountability for PBMs, eliminates gag clauses, and mandates adequate pharmacy networks. It also enables pharmacists to substitute more affordable alternative medications on behalf of patients and allows patients to synchronize their medication fill-dates once a year without cost. Under this new law the common PBM strategy of clawing back dollars from local pharmacies and utilizing rebates for their own self-interest will end.

“One of the drivers of prescription drug cost increases are these middle men,” said Sen. John Jasinski (R-Faribault). “These new reforms will help us get costs under control and give patients information that will help them find the most affordable drug options, without sacrificing care or comfort. This is a big win for Minnesotans.”

Patient protection reforms contained in the bill include:

  • Requires PMBs act in good faith and notify health plans of conflicts of interest.
  • Requires new transparency measures of PBMs.
  • Mandates PBMs disclose any pharmacy ownership interests they have and prohibits them from offering incentives or imposing penalties that could direct patients to pharmacies they own.
  • Prevents pharmacies from dispensing a drug to the consumer if there is a less expensive equivalent.
  • Requires PBMs to disclose out-of-pocket cost differences between preferred network pharmacies and regular, in-network pharmacies.
  • Requires pharmacies to inform customers if they can save money by paying cash for their drugs rather than involving insurance.